Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter CNS imaging Studies

• 1. 使用神经递质的用于原发性情绪和情感障碍的肉毒杆菌毒素 [P] . 中国专利： CN109069609A . 2018-12-21
• 2. 一种鸡EZH2基因对肿瘤性疾病影响的研究方法 [P] . 中国专利： CN113549669A . 2021-10-26
• 3. BOTULINUM TOXIN FOR PRIMARY DISORDERS OF MOOD AND AFFECT USING NEUROTRANSMITTER [P] . 欧洲知识产权局专利： EP3386538A4 . 2019-07-17

  机译： 肉毒杆菌毒素对神经元递质的影响

• 4. botulinum toxin for primary mood and affective disorders using neurotransmitter [P] . BR112018011663A2 . 2018-12-04

  机译： 使用神经递质的肉毒杆菌毒素用于原发性情绪和情感障碍

• 5. Botulinum toxin for primary disorders of mood and affect using neurotransmitter [P] . AU2016366428A1 . 2018-06-28

  机译： 肉毒杆菌毒素可治疗原发性情绪障碍和使用神经递质的影响

• 1. CLINICAL APPLICATION OF BOTULINUM TOXIN TYPE B IN MOVEMENT DISORDERS AND AUTONOMIC SYMPTOMS [J] . Xin-hua Wan, Kevin Dat Vuong, Joseph Jankovic 中国医学科学杂志（英文版） . 2005,第001期
• 2. Botulinum Toxin A, Effect on Tensile Strength of Skin Wounds;Animal Study [J] . Carlos A. Gonzalez-Alvarado, Juan Garzon-Muvdi, Roxanna Perez-Garmendia, 生物科学与医学（英文） . 2020,第002期
• 3. OPEN LABEL PILOT STUDY OF URETHRAL INJECTIONS OF BOTULINUM TOXIN TO TREAT WOMEN IN URINARY RETENTION DUE TO A PRIMARY DISORDER OF URETHRAL SPHINCTER RELAXATION (FOWLER'S SYNDROME) [J] . Panicker J., Seth J., Gonzales G., Neurourology and urodynamics. . 2013,第6期
• 4. The role of toxins in disorders of mood and affect. [J] . Trimble MR, Krishnamoorthy ES Neurologic clinics . 2000,第3期
• 5. Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215O PET study. [J] . Ali SO, Thomassen M, Schulz GM, Journal of speech, language, and hearing research: JSLHR . 2006,第5期
• 6. Effect of Botulinum Toxin on the Spatial Distribution of Biceps Brachii EMG Activity Using a Grid of Surface Electrodes: A Case Study [C] . Babak Afsharipour, Sourav Chandra, Jongsang Son, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2018
• 7. Screening for Bipolar Disorder in the Primary Care Setting Using the Mood Disorder Questionnaire. [D] . Good, Julian David. 2017
• 8. Evaluation of Mood Disorder Patients in a Primary Care Practice: Measures of Affective Temperament Mental Health Risk Factors and Functional Health in a Retrospective Descriptive Study of 35 Patients [O] . Patricia D. Cunningham, Pamela D. Connor, J. Sloan Manning, 2009
• 9. The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders [O] . Pearson Toni, et al 2016
• 10. Heterologous Combinations of Heavy and Light Chains from Botulinum Neurotoxin Aand Tetanus Toxin Inhibit Neurotransmitter Release in Aplysia [R] . Poulain, B., Mochida, S., Weller, U., 1991

• 1. Use of Clostridium botulinum toxin in gastrointestinal motility disorders in children [J] . Ricardo A Arbizu ,Leonel Rodriguez . 世界胃肠内镜杂志：英文版（电子版） . 2015,第5期
• 2. Mood （affective） disorders [J] . lainMachmillan ,AHYoung ,INicolFerrier . 国际内科双语杂志：中英文 . 2004,第12期
• 3. Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study [J] . Beatrice DOrazio ,Girolamo Geraci ,Fausto Famà . 世界临床病例杂志 . 2021,第032期
• 4. 葛花、枳棋子不同比例配伍对酒精性疾病大鼠海马单胺类神经递质的影响 [C] . 王茜 ,钟赣生 ,柳海艳 . 第八届博士生学术年会——中医药与民族医药专题分会场 . 2010
• 5. 浅针治疗原发性失眠的临床疗效及对脑内神经递质的影响 [A] . 张晓峥 . 2017